Kyverna Therapeutics, Inc. KYTX Short- term Investments
Short- term Investments at other companies
Other financials
Where this comes from
Reported directly by Kyverna Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Kyverna Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kyverna Therapeutics, Inc.'s short- term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Kyverna Therapeutics, Inc.'s short- term investments?
- Kyverna Therapeutics, Inc. (KYTX) reported short- term investments of $204.25M in Q1 2026.
- How has Kyverna Therapeutics, Inc.'s short- term investments changed year-over-year?
- Kyverna Therapeutics, Inc.'s short- term investments increased by 9.9% year-over-year, from $185.78M to $204.25M.
- What is the long-term trend for Kyverna Therapeutics, Inc.'s short- term investments?
- Over 2 years (2023 to 2025), Kyverna Therapeutics, Inc.'s short- term investments has grown at a 160.3% compound annual growth rate (CAGR), from $22.9M to $155.16M.